1. Home
  2. Analysis
  3. Famotidine
  4. Equetro

Famotidine and Equetro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Famotidine and Equetro together.

The phase IV clinical study analyzes what interactions people who take Famotidine and Equetro have. It is created by eHealthMe based on reports of 2 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 06, 2023

2 people who take Famotidine and Equetro together, and have interactions are studied.

What is Famotidine?

Famotidine has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 66,153 Famotidine users for its effectiveness, alternative drugs and more.

What is Equetro?

Equetro has active ingredients of carbamazepine. It is often used in bipolar disorder. eHealthMe is studying from 236 Equetro users for its effectiveness, alternative drugs and more.

Number of Famotidine and Equetro reports submitted per year:

Famotidine and Equetro drug interactions.

Common Famotidine and Equetro drug interactions by gender *:

female:

  1. Back pain
  2. Diabetic nephropathy
  3. Nephropathy
  4. Pain
  5. Pulmonary embolism
  6. Systemic lupus erythematosus
  7. Thrombosis
  8. Musculoskeletal pain
  9. Pain in extremity
  10. Road traffic accident

male:

n/a

Common Famotidine and Equetro drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Back pain
  2. Diabetic nephropathy
  3. Nephropathy
  4. Pain
  5. Pulmonary embolism
  6. Systemic lupus erythematosus
  7. Thrombosis
  8. Musculoskeletal pain
  9. Pain in extremity
  10. Road traffic accident

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Famotidine and Equetro?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Famotidine and Equetro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Famotidine side effects:

Browse all side effects of Famotidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Famotidine interactions:

Browse all interactions between Famotidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on famotidine and carbamazepine (the active ingredients of Famotidine and Equetro, respectively), and Famotidine and Equetro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Famotidine and Equetro.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.